Multivariate survival analyses
Variables in model . | No. of patients . | No. of events . | χ2 . | Δχ2 . | P . |
---|---|---|---|---|---|
I. All patients | |||||
A. Base = LN+ + Size+ER+erbB-2 | 645 | 312 | 143.22 | ||
DFS | |||||
Base + Apoptosisa | 645 | 312 | 145.86 | 2.64 | 0.10 |
Base + Mitosisb | 645 | 312 | 143.48 | 0.26 | 0.62 |
Base + Mits−/10 HPFs | 645 | 312 | 143.85 | 0.63 | 0.43 |
Base + MIB-1 | 645 | 312 | 146.22 | 3.53 | 0.06 |
B. Base = LN+ + Size+Grade+ER+erbB-2 | 618 | 235 | 134.54 | ||
DSS | |||||
Base + Apoptosis | 618 | 235 | 135.21 | 0.07 | 0.41c |
Base + Mitosis | 618 | 235 | 135.61 | 1.07 | 0.30 |
Base + Mits/10 HPFs | 618 | 235 | 134.56 | 0.02 | 0.88d |
Base + MIB-1 | 618 | 235 | 137.17 | 2.63 | 0.10d |
II. LN− patients | |||||
A. Base = Size+Grade | 307 | 101 | 19.92 | ||
DFS | |||||
Base + Apoptosis | 307 | 101 | 21.37 | 1.45 | 0.23 |
Base + Mitosis | 307 | 101 | 27.63 | 7.71 | 0.0055c |
Base + Mits/10 HPFs | 307 | 101 | 21.46 | 1.54 | 0.21 |
Base + MIB-1 | 307 | 101 | 22.10 | 2.17 | 0.14c |
B. Base = Grade | 308 | 72 | 8.57 | ||
DSS | |||||
Base + Apoptosis | 308 | 72 | 8.67 | 0.10 | 0.76 |
Base + Mitosis | 308 | 72 | 9.57 | 1.00 | 0.32c |
Base + Mits/10 HPFs | 308 | 72 | 9.61 | 1.04 | 0.20c |
Base + MIB-1 | 308 | 72 | 10.21 | 1.64 | 0.020 |
III. LN+ patients | |||||
A. Base = LN+ + Size+ER+erbB-2 | 327 | 208 | 63.82 | ||
DFS | |||||
Base + Apoptosis | 327 | 208 | 63.96 | 0.13 | 0.72 |
Base + Mitosis | 327 | 208 | 67.94 | 4.11 | 0.043e |
Base + Mits/10 HPFs | 327 | 208 | 65.72 | 1.90 | 0.17 |
Base + MIB-1 | 327 | 208 | 64.38 | 0.55 | 0.46 |
B. Base = LN+ + Age+ER+erbB-2 | 325 | 171 | 79.34 | ||
DSS | |||||
Base + Apoptosis | 325 | 171 | 81.24 | 1.91 | 0.17 |
Base + Mitosis | 325 | 171 | 81.05 | 1.72 | 0.19 |
Base + Mits/10 HPFs | 325 | 171 | 79.44 | 0.10 | 0.75 |
Base + MIB-1 | 325 | 171 | 83.01 | 3.68 | 0.06 |
Variables in model . | No. of patients . | No. of events . | χ2 . | Δχ2 . | P . |
---|---|---|---|---|---|
I. All patients | |||||
A. Base = LN+ + Size+ER+erbB-2 | 645 | 312 | 143.22 | ||
DFS | |||||
Base + Apoptosisa | 645 | 312 | 145.86 | 2.64 | 0.10 |
Base + Mitosisb | 645 | 312 | 143.48 | 0.26 | 0.62 |
Base + Mits−/10 HPFs | 645 | 312 | 143.85 | 0.63 | 0.43 |
Base + MIB-1 | 645 | 312 | 146.22 | 3.53 | 0.06 |
B. Base = LN+ + Size+Grade+ER+erbB-2 | 618 | 235 | 134.54 | ||
DSS | |||||
Base + Apoptosis | 618 | 235 | 135.21 | 0.07 | 0.41c |
Base + Mitosis | 618 | 235 | 135.61 | 1.07 | 0.30 |
Base + Mits/10 HPFs | 618 | 235 | 134.56 | 0.02 | 0.88d |
Base + MIB-1 | 618 | 235 | 137.17 | 2.63 | 0.10d |
II. LN− patients | |||||
A. Base = Size+Grade | 307 | 101 | 19.92 | ||
DFS | |||||
Base + Apoptosis | 307 | 101 | 21.37 | 1.45 | 0.23 |
Base + Mitosis | 307 | 101 | 27.63 | 7.71 | 0.0055c |
Base + Mits/10 HPFs | 307 | 101 | 21.46 | 1.54 | 0.21 |
Base + MIB-1 | 307 | 101 | 22.10 | 2.17 | 0.14c |
B. Base = Grade | 308 | 72 | 8.57 | ||
DSS | |||||
Base + Apoptosis | 308 | 72 | 8.67 | 0.10 | 0.76 |
Base + Mitosis | 308 | 72 | 9.57 | 1.00 | 0.32c |
Base + Mits/10 HPFs | 308 | 72 | 9.61 | 1.04 | 0.20c |
Base + MIB-1 | 308 | 72 | 10.21 | 1.64 | 0.020 |
III. LN+ patients | |||||
A. Base = LN+ + Size+ER+erbB-2 | 327 | 208 | 63.82 | ||
DFS | |||||
Base + Apoptosis | 327 | 208 | 63.96 | 0.13 | 0.72 |
Base + Mitosis | 327 | 208 | 67.94 | 4.11 | 0.043e |
Base + Mits/10 HPFs | 327 | 208 | 65.72 | 1.90 | 0.17 |
Base + MIB-1 | 327 | 208 | 64.38 | 0.55 | 0.46 |
B. Base = LN+ + Age+ER+erbB-2 | 325 | 171 | 79.34 | ||
DSS | |||||
Base + Apoptosis | 325 | 171 | 81.24 | 1.91 | 0.17 |
Base + Mitosis | 325 | 171 | 81.05 | 1.72 | 0.19 |
Base + Mits/10 HPFs | 325 | 171 | 79.44 | 0.10 | 0.75 |
Base + MIB-1 | 325 | 171 | 83.01 | 3.68 | 0.06 |